Please assess the completion status of the following clinical trial:

Trial Title: Test on a New Experimental Mouth Rinse for Relieving Tooth Sensitivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females at least 18 years of age in good general and oral health without any known allergy to commercial dental products or cosmetics.~* Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the study~* Females of childbearing potential must be using a medically-acceptable method of birth control for at least one month prior to Visit 1 and agree to continue using this method during their participation in the study. Acceptable methods for this study include:~* Abstinence~* Birth control pills, patches, vaginal rings, implants or injections~* Intrauterine device~* Double barrier method (condom/diaphragm or cervical cap with spermicide)~* Bilateral tubal ligation~* Hysterectomy~* Ovariectomy~* Male partner vasectomy~* Willingness to use the assigned products according to instructions, availability for appointments, and likelihood of completing the clinical study.~* A minimum of 2 natural premolars, canines, and/or incisors teeth with decay-free scorable facial/buccal surfaces which must present cervical abrasion, and/or erosion and/or gingival recession.~* A minimum of two eligible teeth (premolars, canines and/or incisors) with a Screening (-2 weeks Baseline) and Baseline cold air stimulus Visual Analogue Scale (VAS) score of 40 - 80 mm on a 100 mm VAS scale, tactile sensitivity score between 10 - 30 grams after application of the Yeaple probe and a tactile (Yeaple probe) VAS of 40 -80 mm on a 100 mm VAS scale.~* No more than two eligible teeth per quadrant each separated by 2 other teeth must be selected.~* Absence of significant oral soft tissue pathology, based on the dentist's visual examination and at the discretion of the investigator.~* Adequate oral hygiene (i.e. brush teeth daily and exhibit no signs of oral neglect).~* Absence of severe marginal gingivitis, moderate/advanced periodontitis (ADA Type III, IV) based on a clinical examination and discretion of the Investigator.~* Absence of extensive absence of extensive calculus above the gum line.~Exclusion Criteria:~* Volunteers who report history or presence of kidney disorders, kidney stones, have celiac disease, inflammatory bowel disease (ulcerative colitis or Crohn's disease), chronic pancreatitis, have had intestinal or weight-loss surgery, or if have stomach or intestinal problems that keep them from absorbing certain foods or nutrients.~* Volunteers with eating disorders, uncontrolled Gastroesophageal reflux disease GERD or Acid Reflux, excessive dietary or environmental exposure to acids, or other systemic conditions that are predisposing to dentinal hypersensitivity.~* Volunteers with chronic medical debilitating disease associated with constant or intermittent episodes of daily pain.~* Long-term daily use (≥ 7 consecutive days) of analgesics and any other drugs that at the discretion of the Investigator would compromise the response of the hypersensitivity assessments.~* Volunteers who have been using any home-care bleaching, whitening products or have had a professional bleaching treatment within 4 weeks of the Screening visit.~* Use of desensitizing agents whether prescribed or over-the-counter within eight weeks prior to screening visit (any sensitivity toothpastes such as Crest Sensitivity, Sensodyne, Crest Pro-Health, Colgate Sensitivity Relief, any mouthwash and oral care products used for the treatment of dentinal hypersensitivity).~* Volunteers who during the study will receive dental treatment which may affect their dentinal hypersensitivity condition (i.e., oral prophylaxis). Emergency treatment will be allowed.~* Those with a known allergy to study products' ingredients.~* Those requiring antibiotic premedication prior to invasive dental procedures.~* Participation in a dental clinical study involving oral care products within the past 30 days.~* Self reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing which can affect interpretation of study results)~* Teeth that are grossly carious, orthodontically banded, abutment teeth for fixed or removable prostheses, crowned teeth, or third molars will not be included in the study.~* Periodontal surgery and orthodontic treatment within previous 3 months.~* Extensive restorative treatment (i.e. extensively restored teeth or teeth with restoration(s) extending into the test area) at the discretion of the Investigator.~* Dental prophylaxis within 2 weeks prior to Screening visit.~* Teeth or periodontium with pathology or defect likely to cause pain.~* Teeth with clinical mobility \> grade 1.~* Relative, partner or staff of any clinical research site personnel~* Participation in any clinical study within 30 days of Visit 1.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- KOX (Type: EXPERIMENTAL): After brushing for at least one-minute using at least one-inch strip of toothpaste, rinse with water and then rinse 60 seconds with 10mL of mouth rinse, twice daily.~Fluoride Toothpaste / Crest® Cavity Protection Regular and Experimental Mouth Rinse 12027-033
- PLA (Type: PLACEBO_COMPARATOR): After brushing for at least one-minute using at least one-inch strip of toothpaste, rinse with water and then rinse 60 seconds with 10mL of mouth rinse, twice daily.~Fluoride Toothpaste/Crest® Cavity Protection Regular and Placebo Mouth Rinse

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete